Immunohistochemical expression of cAMP in fluoroedenite‑induced malignant pleural mesothelioma: Preliminary results

Giuseppe Broggi1, Veronica Filetti2, Gaetano Magro1

  • 1Department of Medical, Surgical Sciences and Advanced Technologies G.F. Ingrassia, Anatomic Pathology, University of Catania, I‑95123 Catania, Italy.

PubMed

Insights

Malignant pleural mesothelioma (MPM) linked to fluoro-edenite fibers shows high cyclic adenosine monophosphate (cAMP) expression. This overexpression correlates with significantly shorter survival times in patients with this asbestos-like fiber-induced cancer.

Area of Science:

  • Oncology
  • Environmental Medicine
  • Molecular Biology

Background:

  • Malignant pleural mesothelioma (MPM) prognosis remains poor despite biological understanding.
  • Asbestos and asbestos-like fibers, such as fluoro-edenite (FE), are primary causes of MPM.
  • High MPM incidence and mortality are noted in Biancavilla, Italy, due to long-term FE fiber exposure.

Purpose of the Study:

  • To investigate the immunohistochemical expression of cyclic adenosine monophosphate (cAMP) in fluoro-edenite (FE)-induced MPM.
  • To explore the correlation between cAMP expression levels and patient survival in FE-induced MPM.

Main Methods:

  • Immunohistochemical analysis of cAMP expression in tumor samples from 10 patients with FE-induced MPM.
  • Correlation analysis between cAMP immunoexpression levels and overall survival data.

Main Results:

  • High cAMP immunoexpression was observed in 50% (5/10) of FE-induced MPM tumors.
  • Low cAMP immunoexpression was observed in the remaining 50% (5/10) of tumors.
  • A significant correlation was found between high cAMP overexpression and decreased overall survival (7.5 months vs. 18 months).

Conclusions:

  • Cyclic adenosine monophosphate (cAMP) pathway may play a role in the pathogenesis of FE-induced MPM.
  • High cAMP expression is associated with poorer prognosis in patients with FE-induced MPM.
  • Targeting the cAMP/PKA/CREB pathway could be a potential therapeutic strategy for MPM.

Related Concept Videos